Implementing a new radioisotope service in the oncology department: Multidisciplinary collaboration for Lu-177 radioligand therapy in prostate cancer

This abstract has open access
Abstract Description
Abstract ID :
HAC61
Submission Type
Proposed Topic (Most preferred): :
Research and Innovations (new projects / technology / innovations / service models)
Authors (including presenting author) :
Lui HLH(1), Liu MKR (1), Li KLA (1), Ng CYS (1), Siu WKS (1), Yuen KK(1)
Affiliation :
Department of Clinical Oncology, Queen Mary Hospital
Introduction :
Implementation of new services relies on effective multidisciplinary collaboration among healthcare professionals. This abstract highlights the successful implementation of Lu-177 radioligand therapy, a new radioisotope service, in the clinical oncology department. Oncologists, physicists and nurses collaborated to develop a treatment protocol, coordinate patient care, optimise radiation protection and ensure accurate administration of Lu-177 radioisotope. The collaboration among these professionals played a crucial role in the successful implementation of this new service, resulting in advancements in treatment approaches in the department.
Objectives :
The objective is to emphasize the significance of multidisciplinary collaboration in the successful implementation of a new radioisotope service in the clinical oncology department, highlighting the collective efforts of diverse healthcare professionals in expanding treatment options and optimising therapeutic process.
Methodology :
Prior to the actual treatment day, the team of oncologists, physicists and nurses conducted preparatory meetings and dry-run sessions for the set-up using the gravity method, a new administration technique in the department. On the treatment day, the patient checked in at the designated time and the nurse proceeded with patient preparations and treatment setups. Simultaneously, physicist received the Lu-177 dose at the isotope lab and performed radioactivity measurements and associated quality assurance tests, ensuring the accuracy of the dose. The oncologist and physicist then collaborated to conduct pre-treatment checks, initiated the infusion, monitored the treatment progress and patient condition at specific time intervals. By following this methodology, patient safety was ensured, and optimal radiation safety was achieved. The collaborative efforts of oncologists, physicists and nurses were critical to the effective establishment and execution of this new radioisotope service. The collective effort of the team ensured optimal patient care and facilitated favourable results in the treatment process.
Result & Outcome :
The implementation of the new radioisotope service through multi-disciplinary collaboration resulted in favourable outcomes and enhanced patient treatment. The integrated efforts from the oncologist, physicist and nurse team played a critical role in ensuring the successful introduction of this new service. This collaborative approach forms a solid foundation in expanding treatment options for patient with metastatic castration resistant prostate cancer
Physicist
,
QMH
Doctor
,
Clinical Oncology Department, Queen Mary Hospital
7 visits